Love Health

August 5, 2008, the United States known as a task force of government press release said: there is no “sufficient evidence” to prove over the age of 75 elderly men routine screening for prostate can reduce the mortality rate of this type of crowd.

U.S. Prevention Services Task Force currently recommends that those who no longer than 75 years, there is no clinical symptoms of men to carry out routine prostate-specific antigen screening.They said there was insufficient evidence to prove that the check on the health of these people is good.

“We are very careful assessment of the current access to the discussion of the pros and cons of testing methods for all the literature and concluded that there was not sufficient evidence that early detection of prostate-specific antigen die of the disease will reduce the number of” Task Force Chairman Nande. Karon, clinical doctorate Master of Public Health, Denver, Colorado Public Health and Environment Department director, said. “For this reason, we recommend that those who suspect that they are suffering from prostate cancer in people with a good doctor communication, a doctor’s examination to assess this risk, combined with their own particular circumstances before deciding whether to inspect.”

This is the organization’s latest statement is not recommended for men of all prostate-specific antigen screening.

Prostate cancer in the United States led to the death of the man’s second-largest disease (the first is lung cancer), according to the American Cancer Society statistics, 6 months, there is a prevalence of men. In our country, the incidence of prostate cancer is not so high, but it was growing rapidly.

Prostate-specific antigen screening can help doctors find prostate cancer early, before clinical symptoms appear that the abnormal test results will be higher. Prostate-specific antigen (PSA) by prostate cells, a protein synthesis, a part of this testing is Xuexun in the PSA. All male body has a certain amount of prostate-specific antigen, but, prostate cancer and other diseases of the prostate so that it will rise.

However, not all of the antigens in patients with prostate cancer have increased, and can not check the identification of the antigen is increased because of cancer or benign disease. Only a biopsy can finally confirm whether the disease was malignant. Some experts believe that PSA screening would lead to anxiety and unnecessary biopsies.

“Prostate-specific antigen screening and psychological barriers, and it really beneficial to the patient need to be further study” in the task force on the 5th of the “scientific analysis of the index,” said. For those younger than 75-year-old male is checking whether the advantages outweigh the disadvantages or the need for further study of more harm than good.